SCHEMBL15615155

SCHEMBL15615155

Cc1c(C(=O)NC2CCN(c3ccc(CN4CC(C)OC(C)C4)cn3)CC2)cccc1-c1cccnc1

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ SMO Q99835 3/20 0.60
▸ PGR P06401 1/20 0.44
▸ GPR183 P32249 1/20 0.44
▸ CD274 Q9NZQ7 1/20 0.42
▸ ALDH1A1 P00352 1/20 0.40
▸ TSHR P16473 1/20 0.40
▸ MAPK1 P28482 1/20 0.40
▸ CXCR4 P61073 1/20 0.39
▸ DRD4 P21917 2/20 0.39
▸ CYP2D6 P10635 1/20 0.39
▸ CCR3 P51677 1/20 0.39
▸ PDE4B Q07343 1/20 0.38
▸ SLC6A5 Q9Y345 1/20 0.38
▸ POLB P06746 1/20 0.38
▸ FLT3 P36888 1/20 0.38
▸ TYRO3 Q06418 1/20 0.38
▸ MERTK Q12866 1/20 0.38
▸ GAS6 Q14393 1/20 0.38
▸ CRHR1 P34998 1/20 0.38
▸ CRHR2 Q13324 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15615151 0.94 SMO (0.60) SMOPGRGPR183CD274CXCR4
SCHEMBL15615157 0.92 SMO (0.60) SMOCD274CXCR4DRD4PDE4B
SCHEMBL15615163 0.92 SMO (0.60) SMOPGRGPR183CXCR4CYP2D6
SCHEMBL16811878 0.91 SMO (0.72) SMOCD274ALDH1A1TSHRMAPK1
SCHEMBL16811943 0.91 SMO (0.60) SMOCD274CYP2D6PDE4B
SCHEMBL16811782 0.90 SMO (0.68) SMOCD274ALDH1A1TSHRMAPK1
SCHEMBL16811937 0.89 SMO (0.64) SMOCD274CXCR4DRD4PDE4B
SCHEMBL15615023 0.89 SMO (0.66) SMOCD274ALDH1A1TSHRMAPK1
SCHEMBL15615029 0.88 SMO (0.65) SMOCD274ALDH1A1TSHRMAPK1
SCHEMBL15615170 0.88 SMO (0.64) SMOCD274CXCR4DRD4CCR3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9512106-B2 Smoothened modulators and methods of use thereof DUKE UNIVERSITY (US) 2016-12-06 — — US disclosed
US-9512106-B2 Smoothened modulators and methods of use thereof DUKE UNIVERSITY (US) 2016-12-06 — — US disclosed
US-20150166509-A1 SMOOTHENED MODULATORS AND METHODS OF USE THEREOF UNIV DUKE (US) 2015-06-18 — — US disclosed
US-20150166509-A1 SMOOTHENED MODULATORS AND METHODS OF USE THEREOF UNIV DUKE (US) 2015-06-18 — — US disclosed
WO-2014043608-A2 SMOOTHENED MODULATORS AND METHODS OF USE THEREOF DUKE UNIVERSITY (US) 2014-03-20 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150166509-A1 SMOOTHENED MODULATORS AND METHODS OF USE THEREOF SMO, SHH, GLI1 SMO 1/4885PGR 3016/4885GPR183 1609/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback